On the New Payment-by-Results Method for Determining the Fair Price of New Drugs. An Application in Oncology

Enzo Ballatori; Salvatore Palazzo; Benedetta Ruggeri; Donatella Morale; Aldo Filice; Carmela Oriolo; Alberto Vergati; Marianna Napoletano; Isidoro Mazzoni

doi:10.33393/grhta.2016.411

On the New Payment-by-Results Method for Determining the Fair Price of New Drugs. An Application in Oncology

Authors

Enzo Ballatori Statistico Medico, Spinetoli (AP) - Italy
Salvatore Palazzo UOC di Oncologia Medica, Azienda Ospedaliera di Cosenza, Cosenza - Italy
Benedetta Ruggeri Governo Clinico, Area Vasta 5, ASUR Marche, Ascoli Piceno - Italy
Donatella Morale Oncologia, Area Vasta 5, ASUR Marche, Ascoli Piceno - Italy
Aldo Filice UOC di Oncologia Medica, Azienda Ospedaliera di Cosenza, Cosenza - Italy
Carmela Oriolo UOC di Farmacia, Azienda Ospedaliera di Cosenza, Cosenza - Italy
Alberto Vergati Dipartimento Farmaceutico, Area Vasta 5, ASUR Marche, Ascoli Piceno - Italy
Marianna Napoletano Dipartimento Farmaceutico, Area Vasta 5, ASUR Marche, Ascoli Piceno - Italy
Isidoro Mazzoni Dipartimento Farmaceutico, Area Vasta 5, ASUR Marche, Ascoli Piceno - Italy

DOI:

https://doi.org/10.33393/grhta.2016.411

Keywords:

Fair price, Payment-by-results, Progression-free survival, Survival distributions

Abstract

A new payment-by-results method, published in a previous issue of this Journal was applied in two Italian oncological centers to show how it is easily implemented. This allowed us to make some considerations concerning clinical oncological research, as well as to draw some conclusions on the possible savings that this approach can deliver to the Italian National Health Service.

Downloads

Download data is not yet available.

Downloads

Published

2016-07-18

How to Cite

Ballatori, E., Palazzo, S., Ruggeri, B., Morale, D., Filice, A., Oriolo, C., Vergati, A., Napoletano, M., & Mazzoni, I. (2016). On the New Payment-by-Results Method for Determining the Fair Price of New Drugs. An Application in Oncology. Global and Regional Health Technology Assessment, 3(2), 62–66. https://doi.org/10.33393/grhta.2016.411